Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

IDEAYA Biosciences (IDYA) Shares Outstanding (2019 - 2025)

IDEAYA Biosciences' Shares Outstanding history spans 7 years, with the latest figure at $87.8 million for Q4 2025.

  • For Q4 2025, Shares Outstanding rose 1.49% year-over-year to $87.8 million; the TTM value through Dec 2025 reached $87.8 million, up 1.49%, while the annual FY2025 figure was $87.8 million, 1.49% up from the prior year.
  • Shares Outstanding for Q4 2025 was $87.8 million at IDEAYA Biosciences, roughly flat from $87.7 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $87.8 million in Q4 2025 and bottomed at $32.3 million in Q1 2021.
  • The 5-year median for Shares Outstanding is $58.0 million (2023), against an average of $61.0 million.
  • The largest annual shift saw Shares Outstanding surged 58.6% in 2021 before it rose 1.49% in 2025.
  • A 5-year view of Shares Outstanding shows it stood at $38.5 million in 2021, then grew by 25.07% to $48.2 million in 2022, then soared by 34.96% to $65.0 million in 2023, then soared by 33.0% to $86.5 million in 2024, then increased by 1.49% to $87.8 million in 2025.
  • Per Business Quant, the three most recent readings for IDYA's Shares Outstanding are $87.8 million (Q4 2025), $87.7 million (Q3 2025), and $87.6 million (Q2 2025).